Kewaunee Scientific Corporation KEQU Ratios & Valuation
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 28.5%-0.1pp | 28.9%+1.9pp | 29.1%+2.5pp | 29.4%+3.4pp | 28.6%+3.1pp | |
| Operating margin | 5.9%-1.5pp | 7%+0.2pp | 6.9%-1.3pp | 7.6%-0.8pp | 7.4%-1.6pp | |
| Net margin | 3.4%-1.3pp | 3.9%-4.1pp | 4.1%-5.3pp | 4.7%-4.5pp | 4.7%-4.5pp | |
| Returns | ||||||
| Return on equity | 13.8%-5.3pp | 16.9%-16.7pp | 18.2%-18.8pp | 20%-18.7pp | 19.1%-21.6pp | |
| Return on invested capital | 15.8%-9.3pp | 17.3%-11.9pp | 25.7%-23.6pp | 28.2%-24.2pp | 25.1%-22.8pp | |
| Efficiency | ||||||
| Asset turnover | 1.5×+0.1× | 1.6×+0.2× | 1.8×+0.2× | 1.6×0.0× | 1.5×-0.1× | |
| Liquidity | ||||||
| Current ratio | 2.2×0.0× | 2.1×0.0× | 2.5×-0.2× | 2.3×-0.2× | 2.2×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.3×0.0× | 0.4×0.0× | 0.3×+0.2× | 0.4×+0.2× | 0.4×+0.2× | |
| Net debt / EBITDA | 0.7×+0.4× | 0.8×0.0× | 0.4×+1.5× | 0.1×+1.0× | 0.3×+1.0× | |
| Per Share | ||||||
| Book value per share | $25.05+15.8% | $23.69+16.7% | $23.36+17.1% | $22.64+19.9% | $21.64+16.1% | |
| Valuation | ||||||
| Market capitalization | $101.96M-34.8% | $113.34M-38.6% | $119.84M+32.6% | $163.09M+2.6% | $97.81M-5.3% | |
| Price / earnings | 10.6×-3.1× | 10.2×-0.3× | 10.2×+5.4× | 13.3×+4.6× | 8.6×+3.1× | |
| Price / sales | 0.4×-0.3× | 0.4×-0.4× | 0.4×0.0× | 0.6×-0.2× | 0.4×-0.1× | |
| Price / book | 1.4×-1.1× | 1.6×-1.4× | 1.7×+0.2× | 2.4×-0.4× | 1.5×-0.4× | |
| EV / EBITDA | 5.1×-2.1× | 5.2×-5.3× | 5.1×+1.8× | 6.6×-0.2× | 4.6×+0.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Kewaunee Scientific Corporation's profit margins?
- Kewaunee Scientific Corporation (KEQU) runs a 28.5% gross margin and a 5.9% operating margin, with a 3.4% net margin.
- Where do Kewaunee Scientific Corporation's ratios come from?
- Every ratio is computed from Kewaunee Scientific Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
